Curi RMB Capital’s Cardlytics CDLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-2,402
Closed -$3.43M 470
2020
Q4
$3.43M Sell
2,402
-1,861
-44% -$1.98M 0.13% 159
2020
Q3
$3.01M Sell
4,263
-1,318
-24% -$958K 0.13% 158
2020
Q2
$3.91M Sell
5,581
-3,686
-40% -$2.13M 0.17% 128
2020
Q1
$3.24M Buy
9,267
+1,687
+22% +$1.19M 0.15% 145
2019
Q4
$4.76M Buy
7,580
+696
+10% +$340K 0.13% 174
2019
Q3
$2.31M Buy
+6,884
New +$2.21M 0.06% 276

Other funds holding CDLX

Curi RMB Capital's CDLX Position: Q1 2021 in Review

Curi RMB Capital sold out of Cardlytics (CDLX) in Q1 2021, closing a stake of 2,402 shares — an estimated $3.43M sold.

Curi RMB Capital first reported a position in CDLX in Q3 2019 and held it in 6 quarters. The position peaked at $4.76M in Q4 2019. 204 funds tracked by Wall St. Rank hold CDLX as of Q1 2021.

  • Curi RMB Capital reported no remaining Cardlytics position as of Q1 2021 after selling out during the quarter.
  • Curi RMB Capital sold 2,402 Cardlytics shares in Q1 2021, an estimated $3.43M.
  • Curi RMB Capital first reported a position in Cardlytics in Q3 2019 and held it in 6 quarters.
  • Curi RMB Capital's Cardlytics position peaked at $4.76M in Q4 2019.
  • 204 funds tracked by Wall St. Rank held Cardlytics as of Q1 2021.

Based on Curi RMB Capital's 13F filing for Q1 2021, filed 12 May 2021.